{"id":"W3153311842","doi":"","title":"Pharmacokinetic Simulations of Intravitreal Aflibercept and Brolucizumab to Explore Results from Clinical Trials","year":2020,"lang":"en","type":"article","venue":"Investigative Ophthalmology & Visual Science","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Bayer (Canada); Université de Montréal","funders":"","keywords":"Aflibercept; Pharmacokinetics; Medicine; Clinical trial; Ophthalmology; Pharmacology; Internal medicine; Bevacizumab; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001012926,0.000624595,0.001156981,0.0005211813,0.0003509349,0.001333605,0.0009648316,0.001602119,0.003769791],"category_scores_gemma":[0.005955406,0.0005572883,0.001363665,0.0006450837,0.0004306521,0.0007513317,0.0003615516,0.00141987,0.0005896346],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001592496,"about_ca_system_score_gemma":0.002966718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03329088,"about_ca_topic_score_gemma":0.01252338,"domain_scores_codex":[0.9996182,0.000156497,0.00001615369,0.00005866971,0.00007442883,0.00007600299],"domain_scores_gemma":[0.9957725,0.003297111,0.0003852534,0.00008436885,0.0003434112,0.000117411],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0006762107,0.0001643808,0.002766872,0.0001220968,0.0001296537,0.0003136433,0.0000759197,0.9834396,0.001588013,0.004350099,0.002528442,0.003845189],"study_design_scores_gemma":[0.0006084869,0.0003604507,0.001278593,0.00002956543,0.0001262609,0.0001425347,0.00006365191,0.9898803,0.001286095,0.002958479,0.00323375,0.00003181887],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9019129,0.004218401,0.03983419,0.003933801,0.0002238284,0.0004138236,0.007321005,0.0003787016,0.04176332],"genre_scores_gemma":[0.9772415,0.001057078,0.008735259,0.000780204,0.00004848258,0.0003619849,0.001790036,0.0001227904,0.009862699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03329088,"threshold_uncertainty_score":0.06619418,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3207981488872198,"score_gpt":0.5104434262543787,"score_spread":0.1896452773671589,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}